Cargando…

Objective Nebuliser Adherence Data as “Proof” of Adherence in the Management of Cystic Fibrosis: A Qualitative Interview Study

PURPOSE: Low adherence to medication via nebulisers is linked to poor clinical outcomes for people with Cystic Fibrosis (PWCF). Advances in technology allow electronic monitoring of nebuliser usage and feedback of objective adherence data to PWCF and clinical teams caring for them. CFHealthHub is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lumley, Elizabeth, Drabble, Sarah J, Scott, Anne, Wildman, Martin J, O’Cathain, Alicia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965329/
https://www.ncbi.nlm.nih.gov/pubmed/35370406
http://dx.doi.org/10.2147/PPA.S353434
_version_ 1784678408728346624
author Lumley, Elizabeth
Drabble, Sarah J
Scott, Anne
Wildman, Martin J
O’Cathain, Alicia
author_facet Lumley, Elizabeth
Drabble, Sarah J
Scott, Anne
Wildman, Martin J
O’Cathain, Alicia
author_sort Lumley, Elizabeth
collection PubMed
description PURPOSE: Low adherence to medication via nebulisers is linked to poor clinical outcomes for people with Cystic Fibrosis (PWCF). Advances in technology allow electronic monitoring of nebuliser usage and feedback of objective adherence data to PWCF and clinical teams caring for them. CFHealthHub is a new intervention that collects and displays objective adherence data in easy-to-read formats with the aim of improving nebuliser adherence and health. There is little understanding of how objective adherence data is perceived by PWCF and healthcare professionals (HCPs). PATIENTS AND METHODS: A qualitative study using semi-structured interviews with 22 PWCF and 31 HCPs who had used the CFHealthHub intervention. RESULTS: Objective adherence data was welcomed by the majority of PWCF in the sample, and HCP delivering the intervention, because the data allowed PWCF to reflect on patterns of adherence or non-adherence. Ease of use and characteristics of data display were important, particularly the use of a “traffic light” system to allow PWCF to easily see if they were meeting their adherence targets. For PWCF objective adherence data was used as “proof to self”, offering reassurance to high adherers, and a wake-up call to those with lower levels of adherence. It could also provide ‘proof to others’ where PWCF had higher levels of adherence than HCP or family members believed. The data could sometimes change HCP perceptions of PWCF’s identities as poor adherers. Where adherence was not high, data was used to facilitate honest discussions between PWCF and HCPs about how to increase adherence. HCPs perceived that it was important to use the data positively to motivate, rather than criticise, PWCF. CONCLUSION: Objective nebuliser adherence data in CFHealthHub can offer proof of adherence to PWCF and HCPs. It is important to use it constructively to facilitate discussions on how to improve adherence.
format Online
Article
Text
id pubmed-8965329
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-89653292022-03-31 Objective Nebuliser Adherence Data as “Proof” of Adherence in the Management of Cystic Fibrosis: A Qualitative Interview Study Lumley, Elizabeth Drabble, Sarah J Scott, Anne Wildman, Martin J O’Cathain, Alicia Patient Prefer Adherence Original Research PURPOSE: Low adherence to medication via nebulisers is linked to poor clinical outcomes for people with Cystic Fibrosis (PWCF). Advances in technology allow electronic monitoring of nebuliser usage and feedback of objective adherence data to PWCF and clinical teams caring for them. CFHealthHub is a new intervention that collects and displays objective adherence data in easy-to-read formats with the aim of improving nebuliser adherence and health. There is little understanding of how objective adherence data is perceived by PWCF and healthcare professionals (HCPs). PATIENTS AND METHODS: A qualitative study using semi-structured interviews with 22 PWCF and 31 HCPs who had used the CFHealthHub intervention. RESULTS: Objective adherence data was welcomed by the majority of PWCF in the sample, and HCP delivering the intervention, because the data allowed PWCF to reflect on patterns of adherence or non-adherence. Ease of use and characteristics of data display were important, particularly the use of a “traffic light” system to allow PWCF to easily see if they were meeting their adherence targets. For PWCF objective adherence data was used as “proof to self”, offering reassurance to high adherers, and a wake-up call to those with lower levels of adherence. It could also provide ‘proof to others’ where PWCF had higher levels of adherence than HCP or family members believed. The data could sometimes change HCP perceptions of PWCF’s identities as poor adherers. Where adherence was not high, data was used to facilitate honest discussions between PWCF and HCPs about how to increase adherence. HCPs perceived that it was important to use the data positively to motivate, rather than criticise, PWCF. CONCLUSION: Objective nebuliser adherence data in CFHealthHub can offer proof of adherence to PWCF and HCPs. It is important to use it constructively to facilitate discussions on how to improve adherence. Dove 2022-03-25 /pmc/articles/PMC8965329/ /pubmed/35370406 http://dx.doi.org/10.2147/PPA.S353434 Text en © 2022 Lumley et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Lumley, Elizabeth
Drabble, Sarah J
Scott, Anne
Wildman, Martin J
O’Cathain, Alicia
Objective Nebuliser Adherence Data as “Proof” of Adherence in the Management of Cystic Fibrosis: A Qualitative Interview Study
title Objective Nebuliser Adherence Data as “Proof” of Adherence in the Management of Cystic Fibrosis: A Qualitative Interview Study
title_full Objective Nebuliser Adherence Data as “Proof” of Adherence in the Management of Cystic Fibrosis: A Qualitative Interview Study
title_fullStr Objective Nebuliser Adherence Data as “Proof” of Adherence in the Management of Cystic Fibrosis: A Qualitative Interview Study
title_full_unstemmed Objective Nebuliser Adherence Data as “Proof” of Adherence in the Management of Cystic Fibrosis: A Qualitative Interview Study
title_short Objective Nebuliser Adherence Data as “Proof” of Adherence in the Management of Cystic Fibrosis: A Qualitative Interview Study
title_sort objective nebuliser adherence data as “proof” of adherence in the management of cystic fibrosis: a qualitative interview study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965329/
https://www.ncbi.nlm.nih.gov/pubmed/35370406
http://dx.doi.org/10.2147/PPA.S353434
work_keys_str_mv AT lumleyelizabeth objectivenebuliseradherencedataasproofofadherenceinthemanagementofcysticfibrosisaqualitativeinterviewstudy
AT drabblesarahj objectivenebuliseradherencedataasproofofadherenceinthemanagementofcysticfibrosisaqualitativeinterviewstudy
AT scottanne objectivenebuliseradherencedataasproofofadherenceinthemanagementofcysticfibrosisaqualitativeinterviewstudy
AT wildmanmartinj objectivenebuliseradherencedataasproofofadherenceinthemanagementofcysticfibrosisaqualitativeinterviewstudy
AT ocathainalicia objectivenebuliseradherencedataasproofofadherenceinthemanagementofcysticfibrosisaqualitativeinterviewstudy